Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling
Sho Tsukamoto(Saitama Medical University), Takenobu Katagiri(Saitama Medical University)
Cited by 122
Related Papers
Mutant Activin-Like Kinase 2 in Fibrodysplasia Ossificans Progressiva are Activated via T203 by BMP Type II Receptors
|Molecular Endocrinology|2014|26
In vivo mouse model of calcific myonecrosis induced by injury
|PLoS ONE|2026|0